Osaic Holdings’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
Other funds holding IMNM
RG
VCM
DCM
ES
Osaic Holdings's IMNM Position: Q1 2026 in Review
Osaic Holdings increased its Immunome (IMNM) stake by 12% in Q1 2026, buying an estimated $4.12K and bringing the position to 1,697 shares worth $37.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5432.
Osaic Holdings first reported a position in IMNM in Q4 2020 and has held it in 15 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.
- Osaic Holdings held 1,697 shares of Immunome worth $37.1K as of Q1 2026.
- Osaic Holdings bought 185 Immunome shares in Q1 2026, an estimated $4.12K.
- Immunome made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5432 holding.
- Osaic Holdings first reported a position in Immunome in Q4 2020 and has held it in 15 quarters since.
- 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.
Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.